Boy’s progressing rash could delay surgeryA preoperative evaluation is requested for a 15-year-old boy who is a renal transplant patient maintained on oral mycophenolate mofetil and tacrolimus. His parents are worried that an itchy rash on his hands and feet, which has been progressing over the last 4 months, will result in postponement of his surgery.
Ivermectin 1% cream extends rosacea remissionResults of a relapse study indicate that patients with moderate-to-severe papulopustular rosacea experienced longer remission when treated with once-daily ivermectin 1% cream compared with initial treatment with twice daily metronidazole 0.75% cream.
Parasites and inflammation fuel rosaceaResearch suggests colonization of demodex relates to immune activation of the skin, and certain individuals show genetic predisposition to rosacea. Greater disease understanding may offer insight into therapeutic approaches.
Rosacea treatment shifts focusClinicians now have a better understanding of rosacea from its potential pathogeneses to the systemic diseases associated with the condition. Learn more
It's rosacea, not acneNearly half of rosacea patients thought they had acne before being diagnosed. Learn how to explain the difference between rosacea and acne to patients and help them get the care they need.
Rosacea: Newer topical therapies are effective and well-tolerated
Rosacea: Newer topical therapies are effective and well-toleratedEmerging therapies for rosacea have a favorable side effect profile and address specific symptoms of the condition; brimonidine, for example, addresses background erythema while ivermectin addresses the papules and pustules.
MauiDerm 2015: New drugs bring promising treatments for derm conditions
MauiDerm 2015: New drugs bring promising treatments for derm conditionsPromising new treatments for rosacea and leishmaniasis are among the highlights of a Maui Derm conference session about new drugs in dermatology.
Combination therapies useful for severe scabies casesDifferent agents have become available for scabies treatment, but topical permethrin cream 5 percent is still the go-to therapy, according to an expert. In combination with oral ivermectin, even the most challenging cases of scabies can be addressed effectively.
Topical ivermectin emerges as option for rosacea
Topical ivermectin emerges as option for rosaceaIn the search for rosacea treatments, topical ivermectin 1 percent cream met its safety endpoints in two pivotal trials that included a total of 910 actively treated subjects, Galderma announced at the 72nd Annual Meeting of the American Academy of Dermatology.
Studies yield clues to pathology, treatment of rosaceaNew knowledge regarding rosacea’s pathology may explain why some newer treatment strategies appear effective, while pointing the way for additional approaches, according to an expert who spoke at the American Academy of Dermatology’s annual meeting.